Rx/Reimbursement Adult Incontinence in Sweden

RX/reimbursement adult incontinence saw steady growth in value and volume terms in 2024. Value growth was primarily driven by two key factors: Sweden’s ageing population and the rising prevalence of obesity and type 2 diabetes. A strong correlation exists between age, underlying health conditions and incontinence. The population aged 65+ continues to grow annually, while obesity and type 2 diabetes remains a significant public health concern.

The Rx/Reimbursement adult incontinence in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Rx/Reimbursement adult incontinence market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.